择期肩关节置换术后严重不良事件与终生翻修风险:基于英格兰医院统计数据的 population based 队列研究
该研究基于英格兰NHS医院统计数据库,纳入1998年4月至2017年4月51 895例成人(≥50岁)的58 054例择期肩关节置换术,计算终生翻修风险及术后30/90天严重不良事件发生率。终生翻修风险从85岁及以上女性的1/37(2.7%,95%CI 2.6%-2.8%)到55-59岁男性的1/4(23.6%,95%CI 23.2%-24.0%),翻修风险在术后前5年最高。术后30天任何严重不良事件风险为1/28(3.5%,95%CI 3.4%-3.7%),90天为1/22(4.6%,95%CI 4.4%-4.8%)。严重不良事件与年龄增加、合并症及男性性别相关。作者认为这些风险高于既往认识,部分患者风险可能超过潜在获益,应改善医患共同决策。
要点
- 术后30天任何严重不良事件风险为1/28(3.5%,95%CI 3.4%-3.7%),90天为1/22(4.6%,95%CI 4.4%-4.8%)。
- 终生翻修风险从85岁及以上女性的1/37(2.7%,95%CI 2.6%-2.8%)到55-59岁男性的1/4(23.6%,95%CI 23.2%-24.0%)。
- 翻修风险在术后前5年最高。
- 85岁及以上男性中1/5(21.2%,95%CI 17.9%-25.1%)在90天内经历至少一次严重不良事件。
- 50-64岁女性术后30天肺栓塞相对风险为基线人群的61倍(95%CI 50-73)。
适用人群与场景
- 纳入1998年4月至2017年4月英格兰NHS医院统计数据库中51 895例成人(年龄≥50岁)的58 054例择期肩关节置换术。
- 研究场景为择期肩关节置换手术,非急诊或ICU场景。
研究设计与关键结果
- 研究设计为基于人群的队列研究,使用英格兰NHS医院统计数据和民事登记死亡数据,共58 054例择期肩关节置换术,来自51 895例成人(年龄≥50岁),时间范围为1998年4月至2017年4月。
- 1998年至2017年间每年肩关节置换术数量增加5.6倍。
- 终生翻修风险从85岁及以上女性的1/37(2.7%,95%CI 2.6%-2.8%)到55-59岁男性的1/4(23.6%,95%CI 23.2%-24.0%)。
- 术后30天任何严重不良事件风险为1/28(3.5%,95%CI 3.4%-3.7%),90天为1/22(4.6%,95%CI 4.4%-4.8%)。
- 50-64岁女性术后30天肺栓塞相对风险为基线人群的61倍(95%CI 50-73)。
- 严重不良事件与年龄增加、合并症及男性性别相关。
- 85岁及以上男性中1/5(21.2%,95%CI 17.9%-25.1%)在90天内经历至少一次严重不良事件。
- 翻修风险在术后前5年最高。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 研究注册:ClinicalTrials.gov NCT03573765。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为年轻患者(尤其是男性)需要知晓肩关节置换早期失败及需要进一步更复杂翻修手术的较高可能性。
- 作者认为所有患者均应接受严重不良事件风险的咨询。
- 作者认为这些风险高于既往认识,对部分患者可能超过任何潜在获益。
- 作者认为研究结果提示应警惕在年轻和老年患者中无节制地扩大肩关节置换手术。
- 作者认为该研究更准确的年龄和性别特异性风险估计早该进行,应改善患者与临床医生之间的共同决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To provide accurate risk estimates of serious adverse events after elective shoulder replacement surgery for arthritis, including age and sex specific estimates of the lifetime risk of revision surgery.
DESIGN: Population based cohort study.
SETTING: Hospital episode statistics for NHS England, including civil registration mortality data.
PARTICIPANTS: 58 054 elective shoulder replacements in 51 895 adults (aged ≥50 years) between April 1998 and April 2017.
MAIN OUTCOME MEASURES: The lifetime risk of revision surgery, calculated using an actuarial life table approach and the cumulative probability method. Rates of serious adverse events at 30 and 90 days post-surgery: pulmonary embolism, myocardial infarction, lower respiratory tract infection, acute kidney injury, urinary tract infection, cerebrovascular events, and all cause death. Secondary outcome measures were the number of surgeries performed each year and Kaplan-Meier estimates of revision risk at 3, 5, 10, and 15 years.
RESULTS: The number of shoulder replacements performed each year increased 5.6-fold between 1998 and 2017. Lifetime risks of revision surgery ranged from 1 in 37 (2.7%, 95% confidence interval 2.6% to 2.8%) in women aged 85 years and older to 1 in 4 (23.6%, 23.2% to 24.0%) in men aged 55-59 years. The risks of revision were highest during the first five years after surgery. The risk of any serious adverse event at 30 days post-surgery was 1 in 28 (3.5%, 3.4% to 3.7%), and at 90 days post-surgery was 1 in 22 (4.6%, 4.4% to 4.8%). At 30 days, the relative risk of pulmonary embolism compared with baseline population risk was 61 (95% confidence interval 50 to 73) for women aged 50-64. Serious adverse events were associated with increasing age, comorbidity, and male sex. 1 in 5 (21.2%, 17.9% to 25.1%) men aged 85 years and older experienced at least one serious adverse event within 90 days.
CONCLUSIONS: Younger patients, particularly men, need to be aware of a higher likelihood of early failure of shoulder replacement and the need for further and more complex revision replacement surgery. All patients should be counselled about the risks of serious adverse events. These risks are higher than previously considered, and for some could outweigh any potential benefits. Our findings caution against unchecked expansion of shoulder replacement surgery in both younger and older patients. The more accurate age and sex specific estimates of risk from this study are long overdue and should improve shared decision making between patients and clinicians.
STUDY REGISTRATION: ClinicalTrials.gov NCT03573765.
参考来源
- Craig RS, Lane JCE, Carr AJ, et al. Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England. BMJ. 2019. PMID: 30786996. doi:10.1136/bmj.l298
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。